Stay updated on Upadacitinib vs Placebo in RA Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Placebo in RA Clinical Trial page.

Latest updates to the Upadacitinib vs Placebo in RA Clinical Trial page
- Check5 days agoChange DetectedFooter now displays Revision: v3.3.2, replacing v3.3.1. This appears to be a minor system update with no changes to the study content or functionality.SummaryDifference0.0%

- Check13 days agoChange DetectedPubMed publications note updated to indicate automatic filling from PubMed and that articles may not be about the study, and the revision label changed from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check20 days agoChange DetectedRheumatoid arthritis and related topics: MedlinePlus Genetics were added to the page, and a generic government funding notice about operating status was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check27 days agoChange DetectedRheumatoid arthritis and the related topic MedlinePlus Genetics were removed from the page's related topics section. This reduces disease-context navigation for readers.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page now includes Related Topics: Rheumatoid arthritis and MedlinePlus Genetics to provide additional context and navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange Detected- Removal of the MedlinePlus Genetics topic on Rheumatoid arthritis, reducing access to genetic information about this condition.SummaryDifference0.1%

Stay in the know with updates to Upadacitinib vs Placebo in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Placebo in RA Clinical Trial page.